Vivos Therapeutics, Inc. last reported quarterly results on Apr 15, 2026, for Q1 FY2026 (the quarter ended Mar 31, 2026): revenue of $5.1 million (+70.5% year over year) and diluted EPS of -$0.52. It usually reports 15–51 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 15–51 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Apr 15, 2026
15 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
5
+70.5%
|
-8
-98.8%
|
-0.52
-15.6%
|
|
Nov 19, 2025
50 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
7
+75.7%
|
-5
-106.4%
|
-0.49
-22.5%
|
|
Aug 20, 2025
51 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
4
-5.8%
|
-5
-159.7%
|
-0.55
+8.3%
|
|
May 15, 2025
45 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
3
-11.8%
|
-4
-2.7%
|
-0.45
+72.4%
|
|
Nov 14, 2024
45 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
4
+16.9%
|
-3
-25.0%
|
-0.40
+77.1%
|
|
Aug 15, 2024
46 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
May 15, 2024
45 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Aug 16, 2023
47 days after quarter end
|
—
ended Jun 30, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- VVOS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Littleton, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1716166
- Former names
- Vivos BioTechnologies, Inc. (until Sep 29, 2017)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.